| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |